Literature DB >> 33385230

The PROSPECT Is Bright for CFTR Modulators.

Kristina Montemayor1, Noah Lechtzin1.   

Abstract

Entities:  

Year:  2021        PMID： 33385230     DOI： 10.1513/AnnalsATS.202007-881ED

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  1 in total

1.  Elexacaftor-Tezacaftor-Ivacaftor as a Final Frontier in the Treatment of Cystic Fibrosis: Definition of the Clinical and Microbiological Implications in a Case-Control Study.

Authors:  Giuseppe Migliorisi; Mirella Collura; Francesca Ficili; Tiziana Pensabene; Dafne Bongiorno; Antonina Collura; Francesca Di Bernardo; Stefania Stefani
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.